Literature DB >> 2172787

Differential effects of the adenovirus E1A oncogene on members of the AP-1 transcription factor family.

H van Dam1, R Offringa, I Meijer, B Stein, A M Smits, P Herrlich, J L Bos, A J van der Eb.   

Abstract

The adenovirus early region 1A (E1A) oncogene interferes with the expression level and activity of the AP-1 transcription factor family. E1A abolished the transactivating function of AP-1 (Jun/Fos), which binds to the 12-O-tetradecanoylphorbol-13-acetate-responsive element of the collagenase gene (collTRE). In contrast, the activity of another member of the AP-1 family that binds to the c-junTRE was not repressed. The mRNA expression of the c-jun gene was, in fact, strongly elevated in various cell types expressing the E1A gene of either adenovirus type 5 (Ad5) or Ad12. The regulation of the junB gene by adenovirus E1A, on the other hand, depended both on the cell type and on the transforming adenovirus serotype. The fact that E1A-induced alterations in the repertoire of AP-1 transcription factors depend on its transforming domain in conserved region 1 suggests that the effects are relevant for the transformation process.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172787      PMCID: PMC361373          DOI: 10.1128/mcb.10.11.5857-5864.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

1.  12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region.

Authors:  P Angel; I Baumann; B Stein; H Delius; H J Rahmsdorf; P Herrlich
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

2.  Enhanced induction of SV40 replication from transformed rat cells by fusion with UV-irradiated normal and repair-deficient human fibroblasts.

Authors:  J L van der Lubbe; P J Abrahams; C M van Drunen; A J van der Eb
Journal:  Mutat Res       Date:  1986-03       Impact factor: 2.433

Review 3.  Adenovirus promoters and E1A transactivation.

Authors:  A J Berk
Journal:  Annu Rev Genet       Date:  1986       Impact factor: 16.830

4.  Identification of separate domains in the adenovirus E1A gene for immortalization activity and the activation of virus early genes.

Authors:  E Moran; B Zerler; T M Harrison; M B Mathews
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

5.  An adenovirus E1a protein region required for transformation and transcriptional repression.

Authors:  J W Lillie; M Green; M R Green
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

6.  Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor.

Authors:  P Angel; M Imagawa; R Chiu; B Stein; R J Imbra; H J Rahmsdorf; C Jonat; P Herrlich; M Karin
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

7.  E1A control of gene expression is mediated by sequences 5' to the transcriptional starts of the early viral genes.

Authors:  D L Weeks; N C Jones
Journal:  Mol Cell Biol       Date:  1983-07       Impact factor: 4.272

8.  Repression of the immunoglobulin heavy chain enhancer by the adenovirus-2 E1A products.

Authors:  R Hen; E Borrelli; P Chambon
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

9.  The release of growth arrest by microinjection of adenovirus E1A DNA.

Authors:  S Stabel; P Argos; L Philipson
Journal:  EMBO J       Date:  1985-09       Impact factor: 11.598

10.  Characterization of junD: a new member of the jun proto-oncogene family.

Authors:  S I Hirai; R P Ryseck; F Mechta; R Bravo; M Yaniv
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more
  42 in total

1.  A DNA element that regulates expression of an endogenous retrovirus during F9 cell differentiation is E1A dependent.

Authors:  B T Lamb; K Satyamoorthy; D Solter; A Basu; M Q Xu; R Weinmann; C C Howe
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

2.  DNA-binding properties of the E1A-associated 300-kilodalton protein.

Authors:  Y Rikitake; E Moran
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

3.  Analysis with specific polyclonal antiserum indicates that the E1A-associated 300-kDa product is a stable nuclear phosphoprotein that undergoes cell cycle phase-specific modification.

Authors:  P Yaciuk; E Moran
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

4.  E1A dependent up-regulation of c-jun/AP-1 activity.

Authors:  I Kitabayashi; R Chiu; G Gachelin; K Yokoyama
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

5.  E2F1 and E1A(12S) have a homologous activation domain regulated by RB and CBP.

Authors:  D Trouche; T Kouzarides
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

6.  Adenovirus E1A downregulates cJun- and JunB-mediated transcription by targeting their coactivator p300.

Authors:  J S Lee; R H See; T Deng; Y Shi
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

7.  The CtBP binding domain in the adenovirus E1A protein controls CR1-dependent transactivation.

Authors:  K Sollerbrant; G Chinnadurai; C Svensson
Journal:  Nucleic Acids Res       Date:  1996-07-01       Impact factor: 16.971

8.  Strategic attack on host cell gene expression during adenovirus infection.

Authors:  Hongxing Zhao; Fredrik Granberg; Ludmila Elfineh; Ulf Pettersson; Catharina Svensson
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  The N-terminal region of the adenovirus type 5 E1A proteins can repress expression of cellular genes via two distinct but overlapping domains.

Authors:  J C Dorsman; B M Hagmeyer; J Veenstra; P Elfferich; N Nabben; A Zantema; A J van der Eb
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  Upstream regions of the c-jun promoter regulate phorbol ester-induced transcription in U937 leukemic cells.

Authors:  T Unlap; C C Franklin; F Wagner; A S Kraft
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.